(S)-3,5-DHPG (mM/ml), group I mGlu agonist
Be the first to review this product! Submit a review
|
(15 Publications)
MW 183.16 Da, Purity >99%. Selective group I mGlu agonist. Achieve your results faster with highly validated, pure and trusted compounds.
View Alternative Names
1,8-cineole 2-exo-monooxygenase, Albendazole monooxygenase, Albendazole sulfoxidase, CP33, CP34, CP3A4_HUMAN, CYP3, CYP3A, CYP3A3, CYP3A4, CYPIIIA3, CYPIIIA4, Cytochrome P450 3A3, Cytochrome P450 3A4, Cytochrome P450 HLp, Cytochrome P450 NF-25, Cytochrome P450 family 3 subfamily A polypeptide 4, Cytochrome P450 subfamily IIIA polypeptide 4, Cytochrome P450-PCN1, FLJ40498, FLJ41058, G protein coupled receptor family C group 1 member F, GLUR, GLUR8, GPRC1A, GPRC1B, GPRC1C, GPRC1D, GPRC1E, GPRC1F, GPRC1G, GPRC1H, GRM1-Alpha, GRM1_HUMAN, GRM4_HUMAN, GRM5_HUMAN, GRM7_HUMAN, GRM8_HUMAN, GluR-2, GluR-3, GluR-7, Glucocorticoid inducible P450, Glutamate receptor homolog, Glutamate receptor metabotropic 1, Glutamate receptor metabotropic 2, Glutamate receptor metabotropic 3, Glutamate receptor metabotropic 4, Glutamate receptor metabotropic 5, Glutamate receptor metabotropic 6, Glutamate receptor metabotropic 7, Glutamate receptor metabotropic 8, HLP, MGC126680, MGC126724, MGLU1, MGLU7, MGLUR2, MGLUR3, MGLUR6, MGlu3, Metabotropic glutamate receptor 1, Metabotropic glutamate receptor 2, Metabotropic glutamate receptor 3, Metabotropic glutamate receptor 4, Metabotropic glutamate receptor 5, Metabotropic glutamate receptor 5 variant F, Metabotropic glutamate receptor 5 variant G, Metabotropic glutamate receptor 5 variant H, Metabotropic glutamate receptor 6 precursor, Metabotropic glutamate receptor 7, Metabotropic glutamate receptor 8, NF 25, Nifedipine oxidase, OTTHUMP00000206961, OTTHUMP00000214674, OTTHUMP00000214675, P450 III steroid inducible, P450 PCN1, P450, family III, P450C3, PPP1R86, Protein phosphatase 1 regulatory subunit 86, Quinine 3-monooxygenase, SCAR13, Smp_128940, Taurochenodeoxycholate 6-alpha-hydroxylase, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 3, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 4, mGlu2, mGlu4, mGlu5, mGlu6, mGlu8, mGluR1, mGluR4, mGluR5, mGluR7
- Chemical Structure
Lab
Chemical Structure - (S)-3,5-DHPG (mM/ml), group I mGlu agonist (AB144484)
2D chemical structure image of ab144484, (S)-3,5-DHPG (mM/ml), group I mGlu agonist
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CYP3A4 plays a role in the oxidation of small organic molecules making it critical for drug metabolism and drug-drug interactions. It operates as part of a large enzymatic complex in the endoplasmic reticulum. Metabotropic Glutamate Receptors contribute to modulating synaptic plasticity and neuronal excitability. These receptors function as homo- or heterodimers and are linked to signaling pathways that regulate several neurotransmitters. The activity of these mGluRs significantly affects cognitive functions learning memory and responsiveness to stress.
Pathways
CYP3A4 is a central player in the drug metabolism pathway influencing the biotransformation of pharmaceuticals and endogenous compounds. It is related to the regulation of the xenobiotic detoxification pathway. Metabotropic Glutamate Receptors are involved in the glutamate signaling pathway which has strong connections to synaptic plasticity. These receptors are associated with other proteins like NMDA and AMPA receptors influencing neurotransmitter release and signal modulation in neuronal networks.
Publications (15)
Recent publications for all applications. Explore the full list and refine your search
Glia 69:2546-2558 PubMed34339538
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 77:1176-1192.e16 PubMed31999954
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 33:13743-57 PubMed23966696
2013
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 33:5486-98 PubMed23536064
2013
Applications
Unspecified application
Species
Unspecified reactive species
Nature neuroscience 16:449-55 PubMed23434911
2013
Applications
Unspecified application
Species
Unspecified reactive species
Molecular pharmacology 81:120-33 PubMed22021324
2011
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 31:7450-5 PubMed21593328
2011
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 31:6646-53 PubMed21543593
2011
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 163:984-94 PubMed21366553
2011
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 162:974-88 PubMed21054344
2010
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com